tiprankstipranks
Advertisement
Advertisement

HK:2565 Stock Latest News

PegBio Teams with Rani Therapeutics to Pursue Oral Metabolic Therapies
Company AnnouncementsPegBio Teams with Rani Therapeutics to Pursue Oral Metabolic Therapies
9d ago
2565
PegBio Diabetes Drug Clears Key Hurdle Toward China Reimbursement Listing
PremiumCompany Announcements
PegBio Diabetes Drug Clears Key Hurdle Toward China Reimbursement Listing
20d ago
2565
PegBio Completes H-Share Full Circulation, Boosting Free Float in Hong Kong
PremiumCompany Announcements
PegBio Completes H-Share Full Circulation, Boosting Free Float in Hong Kong
23d ago
2565
PegBio Clarifies Board Composition and Governance Committee Roles
PremiumCompany Announcements
PegBio Clarifies Board Composition and Governance Committee Roles
25d ago
2565
PegBio Wins Strong Shareholder Backing for Capital Moves and Governance Changes at AGM
PremiumCompany Announcements
PegBio Wins Strong Shareholder Backing for Capital Moves and Governance Changes at AGM
25d ago
2565
PegBio Secures First HK$61 Million Royalty as Paidakang Diabetes Drug Enters Active Commercial Rollout
PremiumCompany AnnouncementsPegBio Secures First HK$61 Million Royalty as Paidakang Diabetes Drug Enters Active Commercial Rollout
1M ago
2565
PegBio Sets 2025 AGM to Seek Capital Increase and Broad Share Issuance Mandate
Premium
Company Announcements
PegBio Sets 2025 AGM to Seek Capital Increase and Broad Share Issuance Mandate
2M ago
2565
PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline
Premium
Company Announcements
PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline
2M ago
2565
PegBio’s Diabetes Drug Visepegenatide Reaches Key Milestone in China’s Insurance Access Process
PremiumCompany Announcements
PegBio’s Diabetes Drug Visepegenatide Reaches Key Milestone in China’s Insurance Access Process
2M ago
2565
PegBio reshapes board as independent director resigns and new candidate proposed
PremiumCompany Announcements
PegBio reshapes board as independent director resigns and new candidate proposed
2M ago
2565
PegBio outlines board composition and governance committee roles
PremiumCompany Announcements
PegBio outlines board composition and governance committee roles
2M ago
2565
PegBio Cornerstone Investor Extends Lock-Up on 3.37% H-Share Stake
PremiumCompany Announcements
PegBio Cornerstone Investor Extends Lock-Up on 3.37% H-Share Stake
3M ago
2565
PegBio Advances H Share Full Circulation Plan After CSRC Filing Approval
PremiumCompany AnnouncementsPegBio Advances H Share Full Circulation Plan After CSRC Filing Approval
3M ago
2565
PegBio’s Long-Acting Diabetes Candidate CR059 Gains Late-Breaking Spotlight at ADA 2026
Premium
Company Announcements
PegBio’s Long-Acting Diabetes Candidate CR059 Gains Late-Breaking Spotlight at ADA 2026
4M ago
2565
PegBio overhauls company secretary and governance roles ahead of 2026
Premium
Company Announcements
PegBio overhauls company secretary and governance roles ahead of 2026
4M ago
2565
PegBio Narrows 2025 Losses and Secures China Approval for Core Diabetes Drug
PremiumCompany Announcements
PegBio Narrows 2025 Losses and Secures China Approval for Core Diabetes Drug
4M ago
2565
PegBio Taps Tenry Pharmaceutical for Exclusive Paidakang Commercialization in China
PremiumCompany Announcements
PegBio Taps Tenry Pharmaceutical for Exclusive Paidakang Commercialization in China
4M ago
2565
PegBio sets March 23 board meeting to approve 2025 annual results
PremiumCompany Announcements
PegBio sets March 23 board meeting to approve 2025 annual results
4M ago
2565
PegBio Cuts H-Share Board Lot Size to Boost Liquidity
PremiumCompany Announcements
PegBio Cuts H-Share Board Lot Size to Boost Liquidity
4M ago
2565
PegBio’s Circular RNA GLP-1 Candidate Shows Month-Long Effect in First Human Trial
PremiumCompany AnnouncementsPegBio’s Circular RNA GLP-1 Candidate Shows Month-Long Effect in First Human Trial
4M ago
2565
PegBio Formalizes Board Nomination Committee to Bolster Corporate Governance
Premium
Company Announcements
PegBio Formalizes Board Nomination Committee to Bolster Corporate Governance
7M ago
2565
PegBio Raises HK$300 Million Through H-Share Placing to Fund R&D and Overseas Expansion
Premium
Company Announcements
PegBio Raises HK$300 Million Through H-Share Placing to Fund R&D and Overseas Expansion
7M ago
2565

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >